A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V

Fabrizio Tagliavini, Patricia M J Lievens, Christine Tranchant, Jean Marie Warter, Michel Mohr, Giorgio Giaccone, Francesco Perini, Giacomina Rossi, Mario Salmona, Pedro Piccardo, Bernardino Ghetti, Ronald C. Beavis, Orso Bugiani, Blas Frangione, Frances Prelli

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Gerstmann-Str̈ussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val129 being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a ∼7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148 Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the ∼7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Sträussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a ∼7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.

Original languageEnglish
Pages (from-to)6009-6015
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number8
DOIs
StatePublished - Feb 23 2001

Fingerprint

Amyloidogenic Proteins
Peptides
Amyloid
Mutant Proteins
Tissue
Prion Proteins
Prions
Mutation
Brain
Peptide Hydrolases
Endopeptidases
Codon
Mass spectrometry
Sequence Analysis

ASJC Scopus subject areas

  • Biochemistry

Cite this

A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V. / Tagliavini, Fabrizio; Lievens, Patricia M J; Tranchant, Christine; Warter, Jean Marie; Mohr, Michel; Giaccone, Giorgio; Perini, Francesco; Rossi, Giacomina; Salmona, Mario; Piccardo, Pedro; Ghetti, Bernardino; Beavis, Ronald C.; Bugiani, Orso; Frangione, Blas; Prelli, Frances.

In: Journal of Biological Chemistry, Vol. 276, No. 8, 23.02.2001, p. 6009-6015.

Research output: Contribution to journalArticle

Tagliavini, F, Lievens, PMJ, Tranchant, C, Warter, JM, Mohr, M, Giaccone, G, Perini, F, Rossi, G, Salmona, M, Piccardo, P, Ghetti, B, Beavis, RC, Bugiani, O, Frangione, B & Prelli, F 2001, 'A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V', Journal of Biological Chemistry, vol. 276, no. 8, pp. 6009-6015. https://doi.org/10.1074/jbc.M007062200
Tagliavini, Fabrizio ; Lievens, Patricia M J ; Tranchant, Christine ; Warter, Jean Marie ; Mohr, Michel ; Giaccone, Giorgio ; Perini, Francesco ; Rossi, Giacomina ; Salmona, Mario ; Piccardo, Pedro ; Ghetti, Bernardino ; Beavis, Ronald C. ; Bugiani, Orso ; Frangione, Blas ; Prelli, Frances. / A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 8. pp. 6009-6015.
@article{0817a9b441e3407b8ed2a59ff9e50c01,
title = "A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Str{\"a}ussler-Scheinker Disease A117V",
abstract = "Gerstmann-Str̈ussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val129 being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a ∼7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148 Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the ∼7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Str{\"a}ussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a ∼7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.",
author = "Fabrizio Tagliavini and Lievens, {Patricia M J} and Christine Tranchant and Warter, {Jean Marie} and Michel Mohr and Giorgio Giaccone and Francesco Perini and Giacomina Rossi and Mario Salmona and Pedro Piccardo and Bernardino Ghetti and Beavis, {Ronald C.} and Orso Bugiani and Blas Frangione and Frances Prelli",
year = "2001",
month = "2",
day = "23",
doi = "10.1074/jbc.M007062200",
language = "English",
volume = "276",
pages = "6009--6015",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V

AU - Tagliavini, Fabrizio

AU - Lievens, Patricia M J

AU - Tranchant, Christine

AU - Warter, Jean Marie

AU - Mohr, Michel

AU - Giaccone, Giorgio

AU - Perini, Francesco

AU - Rossi, Giacomina

AU - Salmona, Mario

AU - Piccardo, Pedro

AU - Ghetti, Bernardino

AU - Beavis, Ronald C.

AU - Bugiani, Orso

AU - Frangione, Blas

AU - Prelli, Frances

PY - 2001/2/23

Y1 - 2001/2/23

N2 - Gerstmann-Str̈ussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val129 being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a ∼7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148 Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the ∼7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Sträussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a ∼7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.

AB - Gerstmann-Str̈ussler-Scheinker disease (GSS) is a cerebral amyloidosis associated with mutations in the prion protein (PrP) gene (PRNP). The aim of this study was to characterize amyloid peptides purified from brain tissue of a patient with the A117V mutation who was Met/Val heterozygous at codon 129, Val129 being in coupling phase with mutant Val117. The major peptide extracted from amyloid fibrils was a ∼7-kDa PrP fragment. Sequence analysis and mass spectrometry showed that this fragment had ragged N and C termini, starting mainly at Gly88 and Gly90 and ending with Arg148 Glu152, or Asn153. Only Val was present at positions 117 and 129, indicating that the amyloid protein originated from mutant PrP molecules. In addition to the ∼7-kDa peptides, the amyloid fraction contained N- and C-terminal PrP fragments corresponding to residues 23-41, 191-205, and 217-228. Fibrillogenesis in vitro with synthetic peptides corresponding to PrP fragments extracted from brain tissue showed that peptide PrP-(85-148) readily assembled into amyloid fibrils. Peptide PrP-(191-205) also formed fibrillary structures although with different morphology, whereas peptides PrP-(23-41) and PrP-(217-228) did not. These findings suggest that the processing of mutant PrP isoforms associated with Gerstmann-Sträussler-Scheinker disease may occur extracellularly. It is conceivable that full-length PrP and/or large PrP peptides are deposited in the extracellular compartment, partially degraded by proteases and further digested by tissue endopeptidases, originating a ∼7-kDa protease-resistant core that is similar in patients with different mutations. Furthermore, the present data suggest that C-terminal fragments of PrP may participate in amyloid formation.

UR - http://www.scopus.com/inward/record.url?scp=0035937094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035937094&partnerID=8YFLogxK

U2 - 10.1074/jbc.M007062200

DO - 10.1074/jbc.M007062200

M3 - Article

VL - 276

SP - 6009

EP - 6015

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 8

ER -